RÉSUMÉ
Primary open-angle glaucoma (POAG) is a leading cause of irreversible vision loss worldwide, with elevated intraocular pressure (IOP) a major risk factor. Myocilin (MYOC) dominant gain-of-function mutations have been reported in â¼4% of POAG cases. MYOC mutations result in protein misfolding, leading to endoplasmic reticulum (ER) stress in the trabecular meshwork (TM), the tissue that regulates IOP. We use CRISPR-Cas9-mediated genome editing in cultured human TM cells and in a MYOC mouse model of POAG to knock down expression of mutant MYOC, resulting in relief of ER stress. In vivo genome editing results in lower IOP and prevents further glaucomatous damage. Importantly, using an ex vivo human organ culture system, we demonstrate the feasibility of human genome editing in the eye for this important disease.
Sujet(s)
Systèmes CRISPR-Cas , Protéines du cytosquelette/génétique , Protéines de l'oeil/génétique , Édition de gène , Thérapie génétique/méthodes , Glaucome à angle ouvert/thérapie , Glycoprotéines/génétique , Animaux , Lignée cellulaire , Glaucome à angle ouvert/génétique , Humains , Techniques in vitro , SourisRÉSUMÉ
Administration of glucocorticoids induces ocular hypertension in some patients. If untreated, these patients can develop a secondary glaucoma that resembles primary open-angle glaucoma (POAG). The underlying pathology of glucocorticoid-induced glaucoma is not fully understood, due in part to lack of an appropriate animal model. Here, we developed a murine model of glucocorticoid-induced glaucoma that exhibits glaucoma features that are observed in patients. Treatment of WT mice with topical ocular 0.1% dexamethasone led to elevation of intraocular pressure (IOP), functional and structural loss of retinal ganglion cells, and axonal degeneration, resembling glucocorticoid-induced glaucoma in human patients. Furthermore, dexamethasone-induced ocular hypertension was associated with chronic ER stress of the trabecular meshwork (TM). Similar to patients, withdrawal of dexamethasone treatment reduced elevated IOP and ER stress in this animal model. Dexamethasone induced the transcriptional factor CHOP, a marker for chronic ER stress, in the anterior segment tissues, and Chop deletion reduced ER stress in these tissues and prevented dexamethasone-induced ocular hypertension. Furthermore, reduction of ER stress in the TM with sodium 4-phenylbutyrate prevented dexamethasone-induced ocular hypertension in WT mice. Our data indicate that ER stress contributes to glucocorticoid-induced ocular hypertension and suggest that reducing ER stress has potential as a therapeutic strategy for treating glucocorticoid-induced glaucoma.
Sujet(s)
Dexaméthasone/effets indésirables , Stress du réticulum endoplasmique/effets des médicaments et des substances chimiques , Glaucome à angle ouvert/métabolisme , Glucocorticoïdes/effets indésirables , Réseau trabéculaire de la sclère/métabolisme , Animaux , Antinéoplasiques/pharmacologie , Dexaméthasone/pharmacologie , Modèles animaux de maladie humaine , Stress du réticulum endoplasmique/génétique , Délétion de gène , Glaucome à angle ouvert/induit chimiquement , Glaucome à angle ouvert/génétique , Glaucome à angle ouvert/anatomopathologie , Glaucome à angle ouvert/prévention et contrôle , Glucocorticoïdes/pharmacologie , Humains , Souris , Souris transgéniques , Phénylbutyrates/pharmacologie , Réseau trabéculaire de la sclère/anatomopathologie , Facteur de transcription CHOP/génétique , Facteur de transcription CHOP/métabolismeRÉSUMÉ
Ciliopathies are a group of heterogeneous disorders associated with ciliary dysfunction. Diseases in this group display considerable phenotypic variation within individual syndromes and overlapping phenotypes among clinically distinct disorders. Particularly, mutations in CEP290 cause phenotypically diverse ciliopathies ranging from isolated retinal degeneration, nephronophthisis and Joubert syndrome, to the neonatal lethal Meckel-Gruber syndrome. However, the underlying mechanisms of the variable expressivity in ciliopathies are not well understood. Here, we show that components of the BBSome, a protein complex composed of seven Bardet-Biedl syndrome (BBS) proteins, physically and genetically interact with CEP290 and modulate the expression of disease phenotypes caused by CEP290 mutations. The BBSome binds to the N-terminal region of CEP290 through BBS4 and co-localizes with CEP290 to the transition zone (TZ) of primary cilia and centriolar satellites in ciliated cells, as well as to the connecting cilium in photoreceptor cells. Although CEP290 still localizes to the TZ and connecting cilium in BBSome-depleted cells, its localization to centriolar satellites is disrupted and CEP290 appears to disperse throughout the cytoplasm in BBSome-depleted cells. Genetic interactions were tested using Cep290(rd16)- and Bbs4-null mutant mouse lines. Additional loss of Bbs4 alleles in Cep290(rd16/rd16) mice results in increased body weight and accelerated photoreceptor degeneration compared with mice without Bbs4 mutations. Furthermore, double-heterozygous mice (Cep290(+/rd16);Bbs4(+/-)) have increased body weight compared with single-heterozygous animals. Our data indicate that genetic interactions between BBSome components and CEP290 could underlie the variable expression and overlapping phenotypes of ciliopathies caused by CEP290 mutations.
Sujet(s)
Antigènes néoplasiques/génétique , Antigènes néoplasiques/métabolisme , Syndrome de Bardet-Biedl/génétique , Cils vibratiles/métabolisme , Protéines associées aux microtubules/métabolisme , Rétine/anatomopathologie , Animaux , Syndrome de Bardet-Biedl/métabolisme , Sites de fixation , Poids , Protéines du cycle cellulaire , Lignée cellulaire , Centrioles/métabolisme , Protéines du cytosquelette , Modèles animaux de maladie humaine , Cellules HEK293 , Humains , Souris , Souris transgéniques , Protéines associées aux microtubules/génétique , Mutation , Protéines tumorales/génétique , Protéines tumorales/métabolisme , Protéines nucléaires/génétique , Protéines nucléaires/métabolisme , Phénotype , Cellules photoréceptrices/métabolisme , Rétine/métabolismeRÉSUMÉ
Bardet-Biedl syndrome (BBS) is a genetically heterogeneous autosomal recessive disorder characterized by obesity, retinal degeneration, polydactyly, hypogenitalism and renal defects. Recent findings have associated the etiology of the disease with cilia, and BBS proteins have been implicated in trafficking various ciliary cargo proteins. To date, 17 different genes have been reported for BBS among which BBS1 is the most common cause of the disease followed by BBS10, and BBS4. A murine model of Bbs4 is known to phenocopy most of the human BBS phenotypes, and it is being used as a BBS disease model. To better understand the in vivo localization, cellular function, and interaction of BBS4 with other proteins, we generated a transgenic BBS4 mouse expressing the human BBS4 gene under control of the beta actin promoter. The transgene is expressed in various tissues including brain, eye, testis, heart, kidney, and adipose tissue. These mice were further bred to express the transgene in Bbs4 null mice, and their phenotype was characterized. Here we report that despite tissue specific variable expression of the transgene, human BBS4 was able to complement the deficiency of Bbs4 and rescue all the BBS phenotypes in the Bbs4 null mice. These results provide an encouraging prospective for gene therapy for BBS related phenotypes and potentially for other ciliopathies.
Sujet(s)
Syndrome de Bardet-Biedl/génétique , Syndrome de Bardet-Biedl/métabolisme , Expression des gènes , Phénotype , Protéines/génétique , Protéines/métabolisme , Animaux , Cils vibratiles/métabolisme , Modèles animaux de maladie humaine , Femelle , Génotype , Humains , Hydrocéphalie/génétique , Infertilité masculine/génétique , Rein/innervation , Leptine/métabolisme , Mâle , Souris , Souris knockout , Souris transgéniques , Protéines associées aux microtubules , Obésité/génétique , Rétinopathies/génétique , Système nerveux sympathique/métabolisme , Testicule/métabolisme , TransgènesRÉSUMÉ
Bardet-Biedl Syndrome (BBS) is a pleiotropic and genetically heterozygous disorder caused independently by numerous genes (BBS1-BBS17). Seven highly conserved BBS proteins (BBS1, 2, 4, 5, 7, 8 and 9) form a complex known as the BBSome, which functions in ciliary membrane biogenesis. BBS7 is both a unique subunit of the BBSome and displays direct physical interaction with a second BBS complex, the BBS chaperonin complex. To examine the in vivo function of BBS7, we generated Bbs7 knockout mice. Bbs7(-/-) mice show similar phenotypes to other BBS gene mutant mice including retinal degeneration, obesity, ventriculomegaly and male infertility characterized by abnormal spermatozoa flagellar axonemes. Using tissues from Bbs7(-/-) mice, we show that BBS7 is required for BBSome formation, and that BBS7 and BBS2 depend on each other for protein stability. Although the BBSome serves as a coat complex for ciliary membrane proteins, BBS7 is not required for the localization of ciliary membrane proteins polycystin-1, polycystin-2, or bitter taste receptors, but absence of BBS7 leads to abnormal accumulation of the dopamine D1 receptor to the ciliary membrane, indicating that BBS7 is involved in specific membrane protein localization to cilia.
Sujet(s)
Syndrome de Bardet-Biedl/métabolisme , Protéines de transport/métabolisme , Membrane cellulaire/métabolisme , Chaperons moléculaires/métabolisme , Complexes multiprotéiques/métabolisme , Protéines adaptatrices de la transduction du signal , Animaux , Syndrome de Bardet-Biedl/génétique , Syndrome de Bardet-Biedl/anatomopathologie , Protéines de transport/génétique , Membrane cellulaire/génétique , Membrane cellulaire/anatomopathologie , Cils vibratiles/génétique , Cils vibratiles/métabolisme , Cils vibratiles/anatomopathologie , Protéines du cytosquelette , Modèles animaux de maladie humaine , Infertilité masculine/génétique , Infertilité masculine/métabolisme , Infertilité masculine/anatomopathologie , Mâle , Souris , Souris knockout , Chaperons moléculaires/génétique , Complexes multiprotéiques/génétique , Obésité/génétique , Obésité/métabolisme , Obésité/anatomopathologie , Récepteur dopamine D1/génétique , Récepteur dopamine D1/métabolisme , Dégénérescence de la rétine/génétique , Dégénérescence de la rétine/métabolisme , Dégénérescence de la rétine/anatomopathologie , Canaux cationiques TRPP/génétique , Canaux cationiques TRPP/métabolismeRÉSUMÉ
Hydrocephalus is a common neurological disorder that leads to expansion of the cerebral ventricles and is associated with a high rate of morbidity and mortality. Most neonatal cases are of unknown etiology and are likely to have complex inheritance involving multiple genes and environmental factors. Identifying molecular mechanisms for neonatal hydrocephalus and developing noninvasive treatment modalities are high priorities. Here we use a hydrocephalic mouse model of the human ciliopathy Bardet-Biedl Syndrome (BBS) and identify a role for neural progenitors in the pathogenesis of neonatal hydrocephalus. We found that hydrocephalus in this mouse model is caused by aberrant platelet-derived growth factor receptor α (PDGFR-α) signaling, resulting in increased apoptosis and impaired proliferation of chondroitin sulfate proteoglycan 4 (also known as neuron-glial antigen 2 or NG2)(+)PDGFR-α(+) neural progenitors. Targeting this pathway with lithium treatment rescued NG2(+)PDGFR-α(+) progenitor cell proliferation in BBS mutant mice, reducing their ventricular volume. Our findings demonstrate that neural progenitors are crucial in the pathogenesis of neonatal hydrocephalus, and we identify new therapeutic targets for this common neurological disorder.
Sujet(s)
Antigènes/métabolisme , Apoptose/physiologie , Syndrome de Bardet-Biedl/anatomopathologie , Hydrocéphalie/étiologie , Cellules souches neurales/cytologie , Protéoglycanes/métabolisme , Récepteur au PDGF alpha/métabolisme , Transduction du signal/physiologie , Animaux , Technique de Western , Broxuridine , Prolifération cellulaire/effets des médicaments et des substances chimiques , Amorces ADN/génétique , Femelle , Immunohistochimie , Immunoprécipitation , Méthode TUNEL , Lithium/pharmacologie , Imagerie par résonance magnétique , Mâle , Souris , Souches mutantes de souris , Cellules souches neurales/métabolisme , Réaction de polymérisation en chaine en temps réelRÉSUMÉ
BACKGROUND: Hydrocephalus is a heterogeneous disorder with multiple etiologies that are not yet fully understood. Animal models have implicated dysfunctional cilia of the ependyma and choroid plexus in the development of the disorder. In this report, we sought to determine the origin of the ventriculomegaly in four Bardet Biedl syndrome (BBS) mutant mouse strains as models of a ciliopathy. METHODS: Evans Blue dye was injected into the lateral ventricle of wild- type and BBS mutant mice to determine whether obstruction of intra- or extra-ventricular CSF flow contributed to ventriculomegaly. Transmission electron microscopy (TEM) was used to examine the ultrastructure of the choroid plexus, subfornical organ (SFO), subcommisural organ (SCO), and ventricular ependyma to evaluate their ultrastructure and the morphology of their primary and motile cilia. RESULTS AND DISCUSSION: No obstruction of intra- or extra-ventricular CSF flow was observed, implying a communicating form of hydrocephalus in BBS mutant mice. TEM analyses of the mutants showed no evidence of choroidal papillomas or breakdown of the blood:CSF barrier. In contrast, structural defects were observed in a subpopulation of cilia lining the choroid plexus, SFO, and ventricular ependyma. These included disruptions of the microtubular structure of the axoneme and the presence of electron-dense vesicular-like material along the ciliary shaft and at the tips of cilia. CONCLUSIONS: Abnormalities in cilia structure and function have the potential to influence ciliary intraflagellar transport (IFT), cilia maintenance, protein trafficking, and regulation of CSF production. Ciliary structural defects are the only consistent pathological features associated with CSF-related structures in BBS mutant mice. These defects are observed from an early age, and may contribute to the underlying pathophysiology of ventriculomegaly.
RÉSUMÉ
PURPOSE: Mutations in the myocilin gene (MYOC) are the most common known genetic cause of primary open-angle glaucoma (POAG). The purpose of this study was to determine whether topical ocular sodium 4-phenylbutyrate (PBA) treatment rescues glaucoma phenotypes in a mouse model of myocilin-associated glaucoma (Tg-MYOC(Y437H) mice). METHODS: Tg-MYOC(Y437H) mice were treated with PBA eye drops (n = 10) or sterile PBS (n = 8) twice daily for 5 months. Long-term safety and effectiveness of topical PBA (0.2%) on glaucoma phenotypes were examined by measuring intraocular pressure (IOP) and pattern ERG (PERG), performing slit lamp evaluation of the anterior chamber, analyzing histologic sections of the anterior segment, and comparing myocilin levels in the aqueous humor and trabecular meshwork of Tg-MYOC(Y437H) mice. RESULTS: Tg-MYOC(Y437H) mice developed elevated IOP at 3 months of age when compared with wild-type (WT) littermates (n = 24; P < 0.0001). Topical PBA did not alter IOP in WT mice. However, it significantly reduced elevated IOP in Tg-MYOC(Y437H) mice to the level of WT mice. Topical PBA-treated Tg-MYOC(Y437H) mice also preserved PERG amplitudes compared with vehicle-treated Tg-MYOC(Y437H) mice. No structural abnormalities were observed in the anterior chamber of PBA-treated WT and Tg-MYOC(Y437H) mice. Analysis of the myocilin in the aqueous humor and TM revealed that PBA significantly improved the secretion of myocilin and reduced myocilin accumulation as well as endoplasmic reticulum (ER) stress in the TM of Tg-MYOC(Y437H) mice. Furthermore, topical PBA reduced IOP elevated by induction of ER stress via tunicamycin injections in WT mice. CONCLUSIONS: Topical ocular PBA reduces glaucomatous phenotypes in Tg-MYOC(Y437H) mice, most likely by reducing myocilin accumulation and ER stress in the TM. Topical ocular PBA could become a novel treatment for POAG patients with myocilin mutations.
Sujet(s)
Glaucome à angle ouvert/traitement médicamenteux , Solutions ophtalmiques/administration et posologie , Phénylbutyrates/administration et posologie , Administration par voie ophtalmique , Animaux , Antibactériens/pharmacologie , Humeur aqueuse/métabolisme , Protéines du cytosquelette/métabolisme , Modèles animaux de maladie humaine , Oeil/effets des médicaments et des substances chimiques , Protéines de l'oeil/métabolisme , Femelle , Glaucome à angle ouvert/métabolisme , Glycoprotéines/métabolisme , Humains , Immunohistochimie , Pression intraoculaire/effets des médicaments et des substances chimiques , Mâle , Souris , Souris transgéniques , Hypertension oculaire/traitement médicamenteux , Tunicamycine/pharmacologieRÉSUMÉ
There are numerous genes for which loss-of-function mutations do not produce apparent phenotypes even though statistically significant quantitative changes to biological pathways are observed. To evaluate the biological meaning of small effects is challenging. Bardet-Biedl syndrome (BBS) is a heterogeneous autosomal recessive disorder characterized by obesity, retinopathy, polydactyly, renal malformations, learning disabilities and hypogenitalism, as well as secondary phenotypes including diabetes and hypertension. BBS knockout mice recapitulate most human phenotypes including obesity, retinal degeneration and male infertility. However, BBS knockout mice do not develop polydacyly. Here we showed that the loss of BBS genes in mice result in accumulation of Smoothened and Patched 1 in cilia and have a decreased Shh response. Knockout of Bbs7 combined with a hypomorphic Ift88 allele (orpk as a model for Shh dysfuction) results in embryonic lethality with e12.5 embryos having exencephaly, pericardial edema, cleft palate and abnormal limb development, phenotypes not observed in Bbs7(-/-) mice. Our results indicate that BBS genes modulate Shh pathway activity and interact genetically with the intraflagellar transport (IFT) pathway to play a role in mammalian development. This study illustrates an effective approach to appreciate the biological significance of a small effect.
Sujet(s)
Syndrome de Bardet-Biedl/génétique , Syndrome de Bardet-Biedl/métabolisme , Protéines Hedgehog/génétique , Protéines Hedgehog/métabolisme , Protéines associées aux microtubules/génétique , Protéines associées aux microtubules/métabolisme , Protéines mutantes/génétique , Protéines mutantes/métabolisme , Animaux , Cellules cultivées , Cils vibratiles/métabolisme , Femelle , Humains , Mâle , Souris , Souris knockout , Récepteurs patched , Récepteur Patched-1 , Phénotype , Grossesse , Récepteurs de surface cellulaire/génétique , Récepteurs de surface cellulaire/métabolisme , Récepteurs couplés aux protéines G/génétique , Récepteurs couplés aux protéines G/métabolisme , Protéines recombinantes/génétique , Protéines recombinantes/métabolisme , Transduction du signal , Récepteur Smoothened , Transfection , Protéines suppresseurs de tumeurs/génétique , Protéines suppresseurs de tumeurs/métabolismeRÉSUMÉ
Bardet-Biedl syndrome (BBS) is a heterogeneous disorder characterized by obesity, retinopathy, polydactyly, and congenital anomalies. The incidence of hypertension and diabetes are also increased in BBS patients. Mutation of 16 genes independently causes BBS, and seven BBS proteins form the BBSome that promotes ciliary membrane elongation. BBS3 (ARL6), an ADP ribosylation factor-like small GTPase, is not part of the BBSome complex. The in vivo function of BBS3 is largely unknown. Here we developed a Bbs3 knockout model and demonstrate that Bbs3(-/-) mice develop BBS-associated phenotypes, including retinal degeneration, male infertility, and increased body fat. Interestingly, Bbs3(-/-) mice develop some unique phenotypes not seen in other BBS knockout models: no overt obesity, severe hydrocephalus, and elevated blood pressure (shared by some but not all BBS gene knockout mice). We found that endogenous BBS3 and the BBSome physically interact and depend on each other for their ciliary localization. This finding explains the phenotypic similarity between Bbs3(-/-) mice and BBSome subunit knockout mice. Loss of Bbs3 does not affect BBSome formation but disrupts normal localization of melanin concentrating hormone receptor 1 to ciliary membranes and affects retrograde transport of Smoothened inside cilia. We also show that the endogenous BBSome and BBS3 associate with membranes and the membrane association of the BBSome and BBS3 are not interdependent. Differences between BBS mouse models suggest nonoverlapping functions to individual BBS protein.
Sujet(s)
Facteurs d'ADP-ribosylation/génétique , Syndrome de Bardet-Biedl/génétique , Mutation , Facteurs d'ADP-ribosylation/physiologie , Animaux , Encéphale/métabolisme , Exons , Flagelles/métabolisme , Homozygote , Humains , Mâle , Souris , Souris knockout , Microtubules/métabolisme , Obésité/métabolisme , Phénotype , Transport des protéines , Spermatozoïdes/physiologieRÉSUMÉ
Many signaling proteins including G protein-coupled receptors localize to primary cilia, regulating cellular processes including differentiation, proliferation, organogenesis, and tumorigenesis. Bardet-Biedl Syndrome (BBS) proteins are involved in maintaining ciliary function by mediating protein trafficking to the cilia. However, the mechanisms governing ciliary trafficking by BBS proteins are not well understood. Here, we show that a novel protein, Leucine-zipper transcription factor-like 1 (LZTFL1), interacts with a BBS protein complex known as the BBSome and regulates ciliary trafficking of this complex. We also show that all BBSome subunits and BBS3 (also known as ARL6) are required for BBSome ciliary entry and that reduction of LZTFL1 restores BBSome trafficking to cilia in BBS3 and BBS5 depleted cells. Finally, we found that BBS proteins and LZTFL1 regulate ciliary trafficking of hedgehog signal transducer, Smoothened. Our findings suggest that LZTFL1 is an important regulator of BBSome ciliary trafficking and hedgehog signaling.
Sujet(s)
Syndrome de Bardet-Biedl/métabolisme , Protéines Hedgehog/métabolisme , Récepteurs couplés aux protéines G/génétique , Facteurs de transcription/métabolisme , Animaux , Syndrome de Bardet-Biedl/génétique , Cils vibratiles/génétique , Cils vibratiles/métabolisme , Cellules HEK293 , Humains , Souris , Souris de lignée C57BL , Souris transgéniques , Protéines associées aux microtubules/génétique , Protéines associées aux microtubules/métabolisme , Transport des protéines/génétique , Petit ARN interférent/génétique , Petit ARN interférent/métabolisme , Récepteurs couplés aux protéines G/métabolisme , Transduction du signal , Récepteur Smoothened , Facteurs de transcription/génétiqueRÉSUMÉ
Mutations in myocilin (MYOC) are the most common genetic cause of primary open angle glaucoma (POAG), but the mechanisms underlying MYOC-associated glaucoma are not fully understood. Here, we report the development of a transgenic mouse model of POAG caused by the Y437H MYOC mutation; the mice are referred to herein as Tg-MYOC(Y437H) mice. Analysis of adult Tg-MYOC(Y437H) mice, which we showed express human MYOC containing the Y437H mutation within relevant eye tissues, revealed that they display glaucoma phenotypes (i.e., elevated intraocular pressure [IOP], retinal ganglion cell death, and axonal degeneration) closely resembling those seen in patients with POAG caused by the Y437H MYOC mutation. Mutant myocilin was not secreted into the aqueous humor but accumulated in the ER of the trabecular meshwork (TM), thereby inducing ER stress in the TM of Tg-MYOC(Y437H) mice. Furthermore, chronic and persistent ER stress was found to be associated with TM cell death and elevation of IOP in Tg-MYOC(Y437H) mice. Reduction of ER stress with a chemical chaperone, phenylbutyric acid (PBA), prevented glaucoma phenotypes in Tg-MYOC(Y437H) mice by promoting the secretion of mutant myocilin in the aqueous humor and by decreasing intracellular accumulation of myocilin in the ER, thus preventing TM cell death. These results demonstrate that ER stress is linked to the pathogenesis of POAG and may be a target for treatment in human patients.
Sujet(s)
Réticulum endoplasmique/effets des médicaments et des substances chimiques , Réticulum endoplasmique/métabolisme , Glaucome à angle ouvert/traitement médicamenteux , Glaucome à angle ouvert/physiopathologie , Phénylbutyrates/pharmacologie , Phénylbutyrates/usage thérapeutique , Stress physiologique , Animaux , Apoptose/physiologie , Cellules cultivées , Protéines du cytosquelette/génétique , Réticulum endoplasmique/anatomopathologie , Protéines de l'oeil/génétique , Glaucome à angle ouvert/génétique , Glaucome à angle ouvert/anatomopathologie , Glycoprotéines/génétique , Humains , Pression intraoculaire , Souris , Souris transgéniques , Mutation , Phénotype , Réseau trabéculaire de la sclère/cytologie , Réseau trabéculaire de la sclère/métabolisme , Réseau trabéculaire de la sclère/anatomopathologie , Transgènes , Réponse aux protéines mal repliéesRÉSUMÉ
Bardet-Biedl Syndrome (BBS) is a heterogeneous syndromic form of retinal degeneration. We have identified a novel transcript of a known BBS gene, BBS3 (ARL6), which includes an additional exon. This transcript, BBS3L, is evolutionally conserved and is expressed predominantly in the eye, suggesting a specialized role in vision. Using antisense oligonucleotide knockdown in zebrafish, we previously demonstrated that bbs3 knockdown results in the cardinal features of BBS in zebrafish, including defects to the ciliated Kupffer's Vesicle and delayed retrograde melanosome transport. Unlike bbs3, knockdown of bbs3L does not result in Kupffer's Vesicle or melanosome transport defects, rather its knockdown leads to impaired visual function and mislocalization of the photopigment green cone opsin. Moreover, BBS3L RNA, but not BBS3 RNA, is sufficient to rescue both the vision defect as well as green opsin localization in the zebrafish retina. In order to demonstrate a role for Bbs3L function in the mammalian eye, we generated a Bbs3L-null mouse that presents with disruption of the normal photoreceptor architecture. Bbs3L-null mice lack key features of previously published Bbs-null mice, including obesity. These data demonstrate that the BBS3L transcript is required for proper retinal function and organization.
Sujet(s)
Facteurs d'ADP-ribosylation/métabolisme , Vision , Protéines de poisson-zèbre/métabolisme , Facteurs d'ADP-ribosylation/composition chimique , Facteurs d'ADP-ribosylation/déficit , Facteurs d'ADP-ribosylation/génétique , Séquence d'acides aminés , Animaux , Syndrome de Bardet-Biedl/complications , Syndrome de Bardet-Biedl/génétique , Syndrome de Bardet-Biedl/anatomopathologie , Syndrome de Bardet-Biedl/physiopathologie , Malformations oculaires/complications , Malformations oculaires/anatomopathologie , Malformations oculaires/physiopathologie , Ganglions/effets des médicaments et des substances chimiques , Ganglions/métabolisme , Ganglions/anatomopathologie , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Techniques de knock-down de gènes , Humains , Souris , Souches mutantes de souris , Données de séquences moléculaires , Oligonucléotides antisens/pharmacologie , Spécificité d'organe/effets des médicaments et des substances chimiques , Phénotype , Cellules photoréceptrices de vertébré/effets des médicaments et des substances chimiques , Cellules photoréceptrices de vertébré/métabolisme , Cellules photoréceptrices de vertébré/anatomopathologie , Isoformes de protéines/composition chimique , Isoformes de protéines/génétique , Isoformes de protéines/métabolisme , Transport des protéines/effets des médicaments et des substances chimiques , ARN messager/génétique , ARN messager/métabolisme , Réflexe de sursaut/effets des médicaments et des substances chimiques , Opsines des bâtonnets/métabolisme , Vision/effets des médicaments et des substances chimiques , Danio zébré , Protéines de poisson-zèbre/composition chimique , Protéines de poisson-zèbre/génétiqueRÉSUMÉ
Obesity is a major public health problem in most developed countries and a major risk factor for diabetes and cardiovascular disease. Emerging evidence indicates that ciliary dysfunction can contribute to human obesity but the underlying molecular and cellular mechanisms are unknown. Bardet-Biedl syndrome (BBS) is a genetically heterogeneous human obesity syndrome associated with ciliary dysfunction. BBS proteins are thought to play a role in cilia function and intracellular protein/vesicle trafficking. Here, we show that BBS proteins are required for leptin receptor (LepR) signaling in the hypothalamus. We found that Bbs2(-/-), Bbs4(-/-) and Bbs6(-/-) mice are resistant to the action of leptin to reduce body weight and food intake regardless of serum leptin levels and obesity. In addition, activation of hypothalamic STAT3 by leptin is significantly decreased in Bbs2(-/-), Bbs4(-/-) and Bbs6(-/-) mice. In contrast, downstream melanocortin receptor signaling is unaffected, indicating that LepR signaling is specifically impaired in Bbs2(-/-), Bbs4(-/-) and Bbs6(-/-) mice. Impaired LepR signaling in BBS mice was associated with decreased Pomc gene expression. Furthermore, we found that BBS1 protein physically interacts with the LepR and that loss of BBS proteins perturbs LepR trafficking. Our data indicate that BBS proteins mediate LepR trafficking and that impaired LepR signaling underlies energy imbalance in BBS. These findings represent a novel mechanism for leptin resistance and obesity.
Sujet(s)
Syndrome de Bardet-Biedl/métabolisme , Protéines associées aux microtubules/métabolisme , Chaperons moléculaires/métabolisme , Protéines/métabolisme , Récepteurs à la leptine/métabolisme , Transduction du signal , Animaux , Syndrome de Bardet-Biedl/sang , Restriction calorique , Lignée cellulaire , Chaperonines du groupe II , Humains , Hypothalamus/métabolisme , Hypothalamus/anatomopathologie , Leptine/sang , Mélanocortines/métabolisme , Souris , Souris knockout , Neurones/métabolisme , Neurones/anatomopathologie , Pro-opiomélanocortine/métabolisme , Liaison aux protéines , Transport des protéinesRÉSUMÉ
Mutations in a group of genes that contribute to ciliary function cause Bardet-Biedl syndrome (BBS). Most studies of BBS have focused on primary, sensory cilia. Here, we asked whether loss of BBS proteins would also affect motile cilia lining the respiratory tract. We found that BBS genes were expressed in human airway epithelia, and BBS2 and BBS4 localized to cellular structures associated with motile cilia. Although BBS proteins were not required for ciliogenesis, their loss caused structural defects in a fraction of cilia covering mouse airway epithelia. The most common abnormality was bulges filled with vesicles near the tips of cilia. We discovered this same misshapen appearance in airway cilia from Bbs1, Bbs2, Bbs4, and Bbs6 mutant mice. The structural abnormalities were accompanied by functional defects; ciliary beat frequency was reduced in Bbs mutant mice. Previous reports suggested BBS might increase the incidence of asthma. However, compared with wild-type controls, neither airway hyperresponsiveness nor inflammation increased in Bbs2(-/-) or Bbs4(-/-) mice immunized with ovalbumin. Instead, these animals were partially protected from airway hyperresponsiveness. These results emphasize the role of BBS proteins in both the structure and function of motile cilia. They also invite additional scrutiny of motile cilia dysfunction in patients with this disease.
Sujet(s)
Syndrome de Bardet-Biedl/anatomopathologie , Cils vibratiles/anatomopathologie , Protéines associées aux microtubules/génétique , Protéines/génétique , Muqueuse respiratoire/anatomopathologie , Animaux , Forme de la cellule , Cils vibratiles/composition chimique , Cils vibratiles/physiologie , Chaperonines du groupe II , Humains , Hypersensibilité/étiologie , Mâle , Souris , Souris knockout , Chaperons moléculaires/génétiqueRÉSUMÉ
Bardet-Biedl syndrome (BBS) is a genetic disorder with the primary features of obesity, pigmentary retinopathy, polydactyly, renal malformations, mental retardation, and hypogenitalism. Patients with BBS are also at increased risk for diabetes mellitus, hypertension, and congenital heart disease. BBS is known to map to at least six loci: 11q13 (BBS1), 16q21 (BBS2), 3p13-p12 (BBS3), 15q22.3-q23 (BBS4), 2q31 (BBS5), and 20p12 (BBS6). Although these loci were all mapped on the basis of an autosomal recessive mode of inheritance, it has recently been suggested-on the basis of mutation analysis of the identified BBS2, BBS4, and BBS6 genes-that BBS displays a complex mode of inheritance in which, in some families, three mutations at two loci are necessary to manifest the disease phenotype. We recently identified BBS1, the gene most commonly involved in Bardet-Biedl syndrome. The identification of this gene allows for further evaluation of complex inheritance. In the present study we evaluate the involvement of the BBS1 gene in a cohort of 129 probands with BBS and report 10 novel BBS1 mutations. We demonstrate that a common BBS1 missense mutation accounts for approximately 80% of all BBS1 mutations and is found on a similar genetic background across populations. We show that the BBS1 gene is highly conserved between mice and humans. Finally, we demonstrate that BBS1 is inherited in an autosomal recessive manner and is rarely, if ever, involved in complex inheritance.